pemafibrate
Kowa Pharmaceuticals
['cardio']
prominent: pemafibrate reduces triglyceride levels but not cardiovascular events in patients with dyslipidemia and t2dm written by ! summary and analysis, as well as more #aha2022 coverage below: 